Clinical Trial Update: Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus Infection [Phase 2]

View source ↗

Summary

This document reports a Phase 2 clinical trial evaluating Tenofovir alafenamide (TAF) in children and adolescents with chronic hepatitis B, currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Tenofovir alafenamide (tenofovir alafenamide)

Snippet

Sponsor: Gilead Sciences | Conditions: Chronic Hepatitis B | Phase 2 | Status: RECRUITING